Working Memory Training in COPD Patients: the Cogtrain-Trial

Overview

General cognitive impairment is highly prevalent in chronic obstructive pulmonary disease (COPD) patients. Domain-specific cognitive impairments include deficits in domains such as cognitive flexibility, verbal memory, working memory, planning, and psychomotor speed; which in general are associated with poor health behaviours, such as infrequent exercising and poor diet. Additional cognitive training may reverse these effects. Recent evidence suggests that working memory training is linked to self-control and, indirectly, to improved lifestyle behaviour including increased physical activity. The investigators hypothesise that enhancing cognitive performance through administering specific working memory training not only improves cognitive function but that it facilitates better adherence to a more active lifestyle and a healthier diet in COPD patients.

Full Title of Study: “The Feasibility of Working Memory Training in COPD Patients and the Efficacy on Cognitive Performance, Self-Control and Stress Response”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Other
    • Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
  • Study Primary Completion Date: July 1, 2019

Interventions

  • Other: Working memory training
    • The working memory intervention training programme consists of a domain-general cognitive working memory training programme. One training session will take 20 to 30 minutes, and participants will have to complete approximately 40 cognitive training sessions. The sham treatment is the same as the intervention training however it does not increase in difficulty. Participants are presented with the same task at the same level of difficulty over and over again. Thus a training effect is not expected.
  • Behavioral: Standardised healthy lifestyle coaching
    • Participants will receive standardised healthy living coaching focusing on healthy diet and daily physical activity.

Arms, Groups and Cohorts

  • Active Comparator: Working memory training
    • Working memory training that increases with difficulty if participants answer two subsequent questions correctly, and standardised healthy lifestyle coaching.
  • Sham Comparator: Sham working memory training
    • Working memory training that does not increase in difficulty, and standardised healthy lifestyle coaching.

Clinical Trial Outcome Measures

Primary Measures

  • Feasibility of the cognitive training in COPD patients as measured through training compliance.
    • Time Frame: 6 months
    • The compliance as well as the acceptability of working memory training in the COPD patient population will be investigated
  • Change in cognitive performance before and after working memory training as assessed through a cognitive test performance battery.
    • Time Frame: 6 months
    • Improvement in cognitive flexibility, planning, and working memory.

Secondary Measures

  • Self-control (impulsivity)
    • Time Frame: 6 months
    • This will be measured using the stop signal task.
  • Chronic stress levels as measured through hair levels of cortisol
    • Time Frame: 6 months
    • An objective measure of stress levels experienced over the last 3 months will be measured using cortisol extracted from a hair sample.
  • Stress levels as measured through the salivary cortisol awakening response
    • Time Frame: 6 months
    • An objective measure of stress will be measured using salivary cortisol awakening response
  • Stress perception as assessed through a perceived stress scale.
    • Time Frame: 6 months
    • A subjective measure of chronic stress will be measured using the perceived stress scale score.
  • Acute stress as assessed through the socially evaluated cold pressor test
    • Time Frame: 6 months
    • Acute stress will be measured using the socially evaluated cold pressor test, heart rate is also monitored.
  • Daily physical activity level
    • Time Frame: 6 months
    • Physical activity data will be collected by an accelerometer using step counts.
  • Mental health, depressive symptoms assessed via the BDI-II
    • Time Frame: 6 months
    • Mental health with respect to depression will be evaluated using the Beck Depression Inventory-second edition (BDI-II)
  • Mental health, anxiety symptoms assessed via the GAD-7
    • Time Frame: 6 months
    • Mental health with respect to anxiety will be evaluated using the Generalised Anxiety Disorder 7 (GAD-7)
  • Physical performance assessed through the 6 minute walk test
    • Time Frame: 6 months
    • Changes in physical performance will be assessed using the 6-minute walking test (6MWT).Two six-minute walk tests (6MWT) will be performed according to ERS/ATS guidelines to measure functional exercise capacity. The best 6MWT will be expressed in percentage of predicted values.
  • Self-determination questionnaire
    • Time Frame: 6 months
    • Motivation will be prior to the enrolment of participants in this study in order to include patients who are motivated to initiate and continue our working memory training. The self-made questionnaire evaluates patient’s reasons for participating in the study in order to assess their intrinsic motivation.
  • Short Performance Battery
    • Time Frame: 6 months
    • The SPPB consists of three types of physical manoeuvres: the balance tests, the gait speed test, and the chair stand test. The results of the different tests result in a score which will be used for analysis.
  • Changes in dietary intake over the intervention period
    • Time Frame: 6 months
    • Changes in dietary intake over the intervention period will be assessed using a food frequency questionnaire.
  • Medication adherence
    • Time Frame: 6 months
    • Medication adherence will be measured using a sem
  • Regulation of Eating Behavior Scale (REBS)
    • Time Frame: 6 months
    • Changes in eating behavior motivation will be investigated using the REBS.
  • Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) Regulation
    • Time Frame: 6 months
    • Changes in exercise motivation will be investigated using the BREQ-2
  • COPD Assessment test (CAT)
    • Time Frame: 6 months
    • Impact of the intervention on quality of life will be done using the brief CAT questionnaire.
  • Anthropometry
    • Time Frame: 6 months
    • Alterations in Anthropometical measures will be evaluated using waist circumference, biometric impedance, and body weight (BMI).
  • Manipulation Check
    • Time Frame: 6 months
    • Participants will be asked to recall key health messages from their personalized healthy lifestyle advice sessions. Responses will be scored as follows: 0 points – field blank or no recall of the message content; 1 point – key points not directly related to the message themes; 2 points – key points directly related to the message themes.

Participating in This Clinical Trial

Inclusion Criteria

  • primary diagnosis of COPD based on the Global Initiative for Chronic obstructive Lung Disease (GOLD) guidelines
  • Patients also need to provide written informed consent
  • Be motivated as evaluated by the self-determination questionnaire

Exclusion Criteria

  • Disease and or disability limiting the ability to undergo a neuropsychological testing battery and/or to follow a working memory training (e.g., blindness)
  • Neurological disorders (e.g., Alzheimer's Disease or cerebrovascular disease)
  • Insufficient mastery of the Dutch language
  • Individuals who during the study period are or will be participating in a PR programme

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Maastricht University Medical Center
  • Collaborator
    • Eatwell
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Sarah W Mount, MSc., +3143829999, sarah.mount@maastrichtuniversity.nl

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.